Phase Genomics: Funding, Investors & Team (Oct 2026)
Phase Genomics creates a biotechnology platform for advancements in agriculture, human health, and industrial biology. Their goal is to assist scientists in making innovative discoveries by offering the most comprehensive and precise genomes and metagenomes possible using their technology.
Phase Genomics has raised $7.0M across 2 funding rounds on record, the most recent an undisclosed round of $1.5M announced in Mar 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Phase Genomics Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Phase Genomics Funding Rounds
Phase Genomics raised $5.5M in a Grant announced in Jun 2022.
1.8 years later, an undisclosed round of $1.5M was announced in Mar 2024.
Phase Genomics Founders and Leadership Team
Contact details for the Phase Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →Phase Genomics Funding Compared to Other Biotechnology Startups
Phase Genomics' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phase Genomics in Biotechnology and Seattle
Companies Similar to Phase Genomics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Phase Genomics Funding FAQs
What does Phase Genomics do?
Phase Genomics creates a biotechnology platform for advancements in agriculture, human health, and industrial biology. Their goal is to assist scientists in making innovative discoveries by offering the most comprehensive and precise genomes and metagenomes possible using their technology.
How much funding has Phase Genomics raised?
Phase Genomics has raised $7.0M across 2 rounds on record. The most recent is an undisclosed round of $1.5M announced in Mar 2024.
When did Phase Genomics last raise funding?
Phase Genomics' most recent funding round on record is an undisclosed round of $1.5M, announced in Mar 2024.
Who founded Phase Genomics?
FundedIQ lists Shawn Sullivan (Founder) at Phase Genomics.
Where is Phase Genomics headquartered?
Phase Genomics is based in Seattle, Washington, United States.
How many employees does Phase Genomics have?
Phase Genomics is in the 11-50 employee band.
How does Phase Genomics' funding compare to other Biotechnology startups?
Phase Genomics' latest round of $1.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Phase Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phase Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.